Nicolas Badenco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicolas Badenco has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Estelle Gandjbakhch
Sorbonne Université, APHP, La Pitié Salpetrière University Hospital , Paris
5 shared publications - Mikael Laredo
Institut de Cardiologie, Hôpital Pitié-Salpêtrière, AP-HP Sorbonne Université , Paris
4 shared publications G. Duthoit
Hôpital Pitié-Salpêtrière, Paris, France
3 shared publications- Alexis Hermida
Cardiac Arrhythmia Service, Amiens-Picardie University Hospital , 1 Rond-Point du Pr Christian Cabrol, F-80054 Amiens Cedex 1
2 shared publications - Antoine Lepillier
Centre Cardiologique du Nord, Saint-Denis, France
2 shared publications C. Himbert
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Cardiology, 47/83 boulevard de l'Hopital, 75013 Paris, France
2 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (10)
Elimination of epicardial late potentials by endocardial ablation in arrhythmogenic right ventricular cardiomyopathy
- 28 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (10)
Open AccessElimination of epicardial late potentials by endocardial ablation in arrhythmogenic right ventricular cardiomyopathy
- 7 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (2) , 269-271
Subcutaneous implantable cardiac defibrillator in Brugada syndrome: a prospective multicentre study
- 7 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (2) , 269-271
Subcutaneous implantable cardiac defibrillator in Brugada syndrome: a prospective multicentre study
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (3) , e011354
Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation: The PARTY-PVI Study
Background: Recurrences of atrial fibrillation (AF) after pulmonary vein isolation (PVI) are mainly due to pulmonary vein reconnection. However, a growing number of patients have AF recurrences despite durable PVI. The optimal ablative strategy for these patients is unknown. We analyzed the impact of current ablation strategies in a large multicenter study. Methods: Patients undergoing a redo ablation for AF and presenting durable PVI were included. The freedom from atrial arrhythmia after pulmonary vein-based, linear-based, electrogram-based, and trigger-based ablation strategies were compared. Results: Between 2010 and 2020, 367 patients (67% men, 63±10 years, 44% paroxysmal) underwent a redo ablation for AF recurrences despite durable PVI at 39 centers. After durable PVI was confirmed, linear-based ablation was performed in 219 (60%) patients, electrogram-based ablation in 168 (45%) patients, trigger-based ablation in 101 (27%) patients, and pulmonary vein-based ablation in 56 (15%) patients. Seven patients (2%) did not undergo any additional ablation during the redo procedure. After 22±19 months of follow-up, 122 (33%) and 159 (43%) patients had a recurrence of atrial arrhythmia at 12 and 24 months, respectively. No significant difference in arrhythmia-free survival was observed between the different ablation strategies. Left atrial dilatation was the only independent factor associated with arrhythmia-free survival (HR, 1.59 [95% CI, 1.13–2.23]; P =0.006). Conclusions: In patients with recurrent AF despite durable PVI, no ablation strategy used alone or in combination during the redo procedure appears to be superior in improving arrhythmia-free survival. Left atrial size is a significant predictor of ablation outcome in this population.
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (3) , e011354
Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation: The PARTY-PVI Study
Background: Recurrences of atrial fibrillation (AF) after pulmonary vein isolation (PVI) are mainly due to pulmonary vein reconnection. However, a growing number of patients have AF recurrences despite durable PVI. The optimal ablative strategy for these patients is unknown. We analyzed the impact of current ablation strategies in a large multicenter study. Methods: Patients undergoing a redo ablation for AF and presenting durable PVI were included. The freedom from atrial arrhythmia after pulmonary vein-based, linear-based, electrogram-based, and trigger-based ablation strategies were compared. Results: Between 2010 and 2020, 367 patients (67% men, 63±10 years, 44% paroxysmal) underwent a redo ablation for AF recurrences despite durable PVI at 39 centers. After durable PVI was confirmed, linear-based ablation was performed in 219 (60%) patients, electrogram-based ablation in 168 (45%) patients, trigger-based ablation in 101 (27%) patients, and pulmonary vein-based ablation in 56 (15%) patients. Seven patients (2%) did not undergo any additional ablation during the redo procedure. After 22±19 months of follow-up, 122 (33%) and 159 (43%) patients had a recurrence of atrial arrhythmia at 12 and 24 months, respectively. No significant difference in arrhythmia-free survival was observed between the different ablation strategies. Left atrial dilatation was the only independent factor associated with arrhythmia-free survival (HR, 1.59 [95% CI, 1.13–2.23]; P =0.006). Conclusions: In patients with recurrent AF despite durable PVI, no ablation strategy used alone or in combination during the redo procedure appears to be superior in improving arrhythmia-free survival. Left atrial size is a significant predictor of ablation outcome in this population.
- 1 January 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (1) , 58-61
Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International Registry
- 1 January 2023
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (1) , 58-61
Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International Registry
- Open Access
- 25 August 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (12) , 1952-1959
Pre-implant predictors of inappropriate shocks with the third-generation subcutaneous implantable cardioverter defibrillator
Despite recent improvements, inappropriate shocks emitted by implanted subcutaneous implantable cardioverter defibrillators (S-ICDs) remain a challenge in ‘real-life’ practice. We aimed to study the pre-implant factors associated with inappropriate shocks for the latest generation of S-ICDs. Three-hundred patients implanted with the third-generation S-ICD system for primary or secondary prevention between January 2017 and March 2020 were included in this multicentre retrospective observational study. A follow-up of at least 6 months and pre-implant screening procedure data were mandatory for inclusion. During a mean follow-up of 22.8 (±11.4) months, 37 patients (12.3%) received appropriate S-ICD shock therapy, whereas 26 patients (8.7%) experienced inappropriate shocks (incidence 4.9 per 100 patient years). The total number of inappropriate shock episodes was 48, with nine patients experiencing multiple episodes. The causes of inappropriate shocks included supraventricular arrhythmias (34.6%) and cardiac (30.7%) or extra-cardiac noise (38.4%) oversensing. Using multivariate analysis, we explored the independent factors associated with inappropriate shocks. These were the availability of less than three sensing vectors during pre-implant screening [hazard ratio (HR), 0.33; 95% confidence interval (CI), 0.11–0.93; P = 0.035], low QRS/T wave ratio in Lead I (for a threshold P < 0.001), history of supraventricular tachycardia (HR, 8.67; 95% CI, 2.80–26.7; P < 0.001), and being overweight (body mass index > 25; HR, 2.66; 95% CI, 1.10–6.45; P = 0.03). Automatic pre-implant screening data are a useful quantitative predictor of inappropriate shocks. Electrocardiogram features should be taken into consideration along with other clinical factors to identify patients at high risk of inappropriate shocks.
- 25 August 2022
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 24 (12) , 1952-1959
Open AccessPre-implant predictors of inappropriate shocks with the third-generation subcutaneous implantable cardioverter defibrillator
Despite recent improvements, inappropriate shocks emitted by implanted subcutaneous implantable cardioverter defibrillators (S-ICDs) remain a challenge in ‘real-life’ practice. We aimed to study the pre-implant factors associated with inappropriate shocks for the latest generation of S-ICDs. Three-hundred patients implanted with the third-generation S-ICD system for primary or secondary prevention between January 2017 and March 2020 were included in this multicentre retrospective observational study. A follow-up of at least 6 months and pre-implant screening procedure data were mandatory for inclusion. During a mean follow-up of 22.8 (±11.4) months, 37 patients (12.3%) received appropriate S-ICD shock therapy, whereas 26 patients (8.7%) experienced inappropriate shocks (incidence 4.9 per 100 patient years). The total number of inappropriate shock episodes was 48, with nine patients experiencing multiple episodes. The causes of inappropriate shocks included supraventricular arrhythmias (34.6%) and cardiac (30.7%) or extra-cardiac noise (38.4%) oversensing. Using multivariate analysis, we explored the independent factors associated with inappropriate shocks. These were the availability of less than three sensing vectors during pre-implant screening [hazard ratio (HR), 0.33; 95% confidence interval (CI), 0.11–0.93; P = 0.035], low QRS/T wave ratio in Lead I (for a threshold P < 0.001), history of supraventricular tachycardia (HR, 8.67; 95% CI, 2.80–26.7; P < 0.001), and being overweight (body mass index > 25; HR, 2.66; 95% CI, 1.10–6.45; P = 0.03). Automatic pre-implant screening data are a useful quantitative predictor of inappropriate shocks. Electrocardiogram features should be taken into consideration along with other clinical factors to identify patients at high risk of inappropriate shocks.
- 1 January 2020
- Published by Elsevier in Heart Rhythm
- Vol. 17 (1) , 41-48
Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy
- 1 January 2020
- Published by Elsevier in Heart Rhythm
- Vol. 17 (1) , 41-48
Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy
- 1 August 2018
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (suppl_1)
2116Outcomes after catheter ablation for treatment of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
Background: Electrical storm (ES) is not rare in patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D). Catheter ablation is an effective treatment for ARVC/D-associated ventricular tachycardia (VT), however its benefit as an urgent treatment for ES in ARVC/D remains to be assessed.
- 1 August 2018
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (suppl_1)
2116Outcomes after catheter ablation for treatment of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
Background: Electrical storm (ES) is not rare in patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D). Catheter ablation is an effective treatment for ARVC/D-associated ventricular tachycardia (VT), however its benefit as an urgent treatment for ES in ARVC/D remains to be assessed.
- 1 January 2018
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 10 (1) , 89-90
Comparison of incidences of pulmonary vein stenosis between radiofrequency and cryoablation in atrial fibrillation ablation
- 1 January 2018
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 10 (1) , 89-90
Comparison of incidences of pulmonary vein stenosis between radiofrequency and cryoablation in atrial fibrillation ablation
- 1 August 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (suppl 1) , P1396
Riata and Riata ST defibrillator leads failure: cable externalization is one problem, but other electrical failures seem more preoccupant
Purpose: Riata and Riata ST leads (St Jude Medical, Sylmar, CA) are recalled insulation failure and cable externalization since 2010. The consequences of this insulation damage are not yet established. We aimed to determine the overall failures and their mechanism in 2 tertiary centres. Methods: All patients with Riata and Riata ST leads implanted and followed between 2003 and 2012, were evaluated with an annual biplane chest x-ray and ICD interrogation every 3 months. Results: 181 patients have been implanted with Riata (94 single-coil and 46 double-coil) and Riata ST (36 single-coil and 5 double-coil) leads. 86 patients have completed a follow-up of 74 months, 22 had heart transplant, 41 died, and 34 patients were referred to other centres or lost. Overall failure rate was 32.5% (28 patients); all were observed in 8-French leads except for one patient. We report 10 oversensing including 5 related to insulation damages and 5 without, none of them have shown cable externalization, 8 conductor fractures, 7 conductor externalizations without electrical abnormality, and 3 other isolated electrical problem such as impedance increase (11.6%, 9.3%, 8.1%, and 3.5% respectively). Mean time to failure was 62 months. Conclusions: Riata lead failure mostly concerns 8-French leads. Attention is especially paid to conductor externalization risk, but global failure rate with electrical complications seems more preoccupant and needs to be emphasised.
- 1 August 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (suppl 1) , P1396
Riata and Riata ST defibrillator leads failure: cable externalization is one problem, but other electrical failures seem more preoccupant
Purpose: Riata and Riata ST leads (St Jude Medical, Sylmar, CA) are recalled insulation failure and cable externalization since 2010. The consequences of this insulation damage are not yet established. We aimed to determine the overall failures and their mechanism in 2 tertiary centres. Methods: All patients with Riata and Riata ST leads implanted and followed between 2003 and 2012, were evaluated with an annual biplane chest x-ray and ICD interrogation every 3 months. Results: 181 patients have been implanted with Riata (94 single-coil and 46 double-coil) and Riata ST (36 single-coil and 5 double-coil) leads. 86 patients have completed a follow-up of 74 months, 22 had heart transplant, 41 died, and 34 patients were referred to other centres or lost. Overall failure rate was 32.5% (28 patients); all were observed in 8-French leads except for one patient. We report 10 oversensing including 5 related to insulation damages and 5 without, none of them have shown cable externalization, 8 conductor fractures, 7 conductor externalizations without electrical abnormality, and 3 other isolated electrical problem such as impedance increase (11.6%, 9.3%, 8.1%, and 3.5% respectively). Mean time to failure was 62 months. Conclusions: Riata lead failure mostly concerns 8-French leads. Attention is especially paid to conductor externalization risk, but global failure rate with electrical complications seems more preoccupant and needs to be emphasised.